The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications.
Burger
Angelika M
AM
Laboratory of Molecular Pathology, Department of Anatomic Pathology, Division of Molecular and Cellular Biology, Sunnybrook and Women's College Health Sciences Centre, S-224, 2075 Bayview Avenue, Toronto, Ont., Canada M4N 3M5. angelikaburger@aol.com
Seth
Arun K
AK
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003546:Cysteine Endopeptidases / Q000378:metabolism; D006801:Humans; D008025:Ligases / Q000378:metabolism; D009097:Multienzyme Complexes / Q000378:metabolism; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D046988:Proteasome Endopeptidase Complex; D011506:Proteins / Q000378:metabolism; D025801:Ubiquitin / Q000378:metabolism*; D044763:Ubiquitin-Conjugating Enzymes / Q000378:metabolism
D000970:Antineoplastic Agents; D009097:Multienzyme Complexes; D011506:Proteins; D025801:Ubiquitin; D044763:Ubiquitin-Conjugating Enzymes; D003546:Cysteine Endopeptidases; D046988:Proteasome Endopeptidase Complex; D008025:Ligases